Schott, D.; Pizon, M.; Drozdz, S.; Mäurer, I.; Wurschi, G.; Pachmann, K.; Mäurer, M.
Circulating Epithelial Tumor Cells (CETC/CTC) in Prostate Cancer: Potential Prognostic Marker for the Risk of Recurrence During Radiotherapy. Int. J. Mol. Sci. 2025, 26, 1548.
https://doi.org/10.3390/ijms26041548
AMA Style
Schott D, Pizon M, Drozdz S, Mäurer I, Wurschi G, Pachmann K, Mäurer M.
Circulating Epithelial Tumor Cells (CETC/CTC) in Prostate Cancer: Potential Prognostic Marker for the Risk of Recurrence During Radiotherapy. International Journal of Molecular Sciences. 2025; 26(4):1548.
https://doi.org/10.3390/ijms26041548
Chicago/Turabian Style
Schott, Dorothea, Monika Pizon, Sonia Drozdz, Irina Mäurer, Georg Wurschi, Katharina Pachmann, and Matthias Mäurer.
2025. "Circulating Epithelial Tumor Cells (CETC/CTC) in Prostate Cancer: Potential Prognostic Marker for the Risk of Recurrence During Radiotherapy" International Journal of Molecular Sciences 26, no. 4: 1548.
https://doi.org/10.3390/ijms26041548
APA Style
Schott, D., Pizon, M., Drozdz, S., Mäurer, I., Wurschi, G., Pachmann, K., & Mäurer, M.
(2025). Circulating Epithelial Tumor Cells (CETC/CTC) in Prostate Cancer: Potential Prognostic Marker for the Risk of Recurrence During Radiotherapy. International Journal of Molecular Sciences, 26(4), 1548.
https://doi.org/10.3390/ijms26041548
